News
Six Game Changers in Implementing CGMs in Your Primary Care Practice - MCT2D Panel Discussion with Recording
Wednesday, September 21, 2022
Fall 2022 Abbott Freestyle Libre CGM Training Series
Tuesday, September 20, 2022
Abbott, a major manufacturer of FreeStyle continuous glucose monitoring (CGM) technology, will host and lead a series of drop-in 30-minute online training webinars in October and November 2022 for participating MCT2D members. Sessions are completely optional and are not hosted or associated with the Michigan Collaborative for Type 2 Diabetes (MCT2D).
Fall 2022 Dexcom-Led Training Series
Tuesday, September 20, 2022
Dexcom, a major manufacturer of continuous glucose monitoring technology, will host and lead a series of 30-minute online training sessions in September-November 2022. Sessions are completely optional and are not hosted or associated with the Michigan Collaborative for Type 2 Diabetes (MCT2D).
August 2022 Learning Community Newsletter
Wednesday, September 7, 2022
LC Blog: How often do you find that you can’t afford your copays?
Wednesday, September 7, 2022
A clinical champion and her patient share insights into Patient Assistance Programs (PAPs)
Celebrating TWO victories in expanding CGM coverage
Wednesday, September 7, 2022
Coverage for CGMs—and related prior authorization and co-pay issues—remains a key barrier in CGM adoption for primary care practices across the state of Michigan.
August 2022 Drop-In Q&A with MCT2D Health Educator and Dietitian, Rina
Thursday, August 25, 2022
Find the most recent Drop-In Q&A session with MCT2D Dietitian and Health Educator, Rina Hisamatsu, recorded August 12. Rina presented alongside program co-director and lead pharmacist Heidi Diez.
July 2022 Learning Community Newsletter
Thursday, August 25, 2022
MCT2D Welcomes New Program Leadership
Thursday, August 25, 2022
Caroline Richardson has stepped down from her role as the program director of the Michigan Collaborative for Type 2 Diabetes effective July 14th to take a role as the chair of family medicine at Brown University. The MCT2D team is incredibly grateful to Dr. Richardson for her vision in establishing the program and leadership in its initial year. We are confident that the strong foundation on which the program was built, will foster continued improvement in type two diabetes care for years to come. More information will be forthcoming, but there will be no changes to the operations of MCT2D. Thank you Dr. Richardson for all that you have done to support our successful launch.
A Note from the Outgoing Director
Recent improvements in medication, technology and dietary counseling for Type 2 Diabetes have the potential to dramatically improve patients’ lives. However, keeping up with all the changes and recommendations can be challenging, and no single provider can go at it alone. In 2021, we established MCT2D as a statewide collaborative designed to support Michigan physicians and care teams as we shift the paradigm of T2D care together, delivering the kind of state-of-the-art care our patients deserve.During our first year, with input from participating physician organizations, practices, and patients from across the state, we have developed tools and educational programs to reduce barriers to delivery of high-quality Type 2 Diabetes care. And we are just getting started!It has been a privilege to lead the collaborative during the first year. I am grateful for the support and collaboration from so many individuals and organizations from across the state. I will be handing over the leadership of the collaborative to a new team of co-directors as of July 14, as I have accepted a new position outside of the state of Michigan, as Chair of Family Medicine at The Warren Alpert Medical School of Brown University. Our fantastic team of quality improvement specialists, designers, data managers, data analysts, and clinical experts will continue the important work of the collaborative.
Caroline Richardson, MD
First Annual Collaborative Wide Meeting Held in June
Thursday, August 25, 2022
